Phosphodiesterase-4 (PDE4) inhibitors belong to a class of medications known as disease-modifying anti-rheumatic drugs (DMARDs). PDE4 inhibitors are prescribed to reduce inflammation and slow down disease progression inpsoriasis, an inflammatory skin condition that can also lead to joint inflammation ...
Harrison C. Trial watch: PDE4 inhibitor leads wave of target- specific oral psoriasis drugs. Nat Rev Drug Discov 2013; 12(5): 335.Harrison C. Trial watch: PDE4 inhibitor leads wave of target-specific oral psoriasis drugs [J]. Nat Rev Drug Discov, 2013, 12(5): 335....
The present invention relates to a composite administration of an anti-arthritis drug or anti-rheumatic drugs and disease modifying antirheumatic drugs PDE3 / 4 inhibitor or (DMARD) or PDE4 of airway disease therapy.ヨハネス バルズィヒ
Novel systemic drugs for psoriasis: mechanism of action for apremilast, a specific inhibitor of PDE4. J Am Acad Dermatol 2013;68(6):1041-2.Schafer PH, Day RM. Novel systemic drugs for psoriasis: mechanism of action for apremilast, a speciic inhibitor of PDE4. J Am Acad Dermatol. 2013;...